Abstract: The present invention provides a composition and method for targeting hypoxic tumor areas for detection or treatment or a treatment adjuvant for cancer. Specifically, a hypoxia targeting moiety is conjugated to a polymeric micelle containing imaging agents, therapeutic agents, or therapeutic adjuvants.

Abstract: The present invention provides a composition and method for targeting hypoxic tumor areas for detection or treatment or a treatment adjuvant for cancer. Specifically, a hypoxia targeting moiety is conjugated to a polymeric micelle containing imaging agents, therapeutic agents, or therapeutic adjuvants.

Abstract: The present invention provides a composition and method for targeting hypoxic tumor areas for detection or treatment or a treatment adjuvant for cancer. Specifically, a hypoxia targeting moiety is conjugated to a polymeric micelle containing imaging agents, therapeutic agents, or therapeutic adjuvants.

Abstract: A method of generating light through chemiluminescence involves providing a stable 1,2-dioxetane of the formula: Wherein (a) R1 and R2 are each, individually, a chemical reactive site or when fused together form a chemical reactive site, and R3 and R4 are each, individually, a chemical reactive site or when fused together form a chemical reactive or (b) R1 has at least two hetero atoms with chemical reactive site and R3 and R4 are inactive site and R2 is a chemical reactive site.

Abstract: A method of generating light through chemiluminescence involves providing a stable 1,2-dioxetane of the formula: Wherein (a) R1 and R2 are each, individually, a chemical reactive site or when fused together form a chemical reactive site, and R3 and R4 are each, individually, a chemical reactive site or when fused together form a chemical reactive or (b) R1 has at least two hetero atoms with chemical reactive site and R3 and R4 are inactive site and R2 is a chemical reactive site.

Abstract: A compound for enhancing the light output of a chemiluminescent system and, in particular, a stabilized, triggerable 1,2-dioxetane, is obtained by reacting a polyvinylbenzyl halide and a bilinker with either a trisubstituted amine or trisubstituted phosphine. A fluorescent molecule may be attached to polymer along with the trisubstituted amine or trisubstituted phosphine. Also, the benzyl halide may be reacted with a ?-electron donor, such as a vinyl naphthalene or vinylanthracene to form a co-polymer which is polymerizable with the trisubstituted amine and/or trisubstituted phosphine. By controlling the reaction parameters it is possible to obtain either a water-soluble or partial water soluble or insoluble compound crosslink polymer.

Abstract: A chemiluminescent 1,2-dioxetane includes an alkaline phosphatase triggerable stable 1,2-dioxetane; a polymeric enhancer which is either an ammonium or phosphonium salt of a polyvinylbenzyl chloride and an aqueous enzyme diluent or stabilizer which corresponds to blood component including blood protein. The system is efficacious for single molecule detection of alkaline phosphatase and other enzymes.

Abstract: A method of generating light through chemiluminescence involves providing a stable 1,2-dioxetane of the formula: 1

Abstract: Chemiluminescent 1,2-dioxetanes derived from substituted aromatic esters or ketones and spiro-fused ketones with either &pgr;-electron system in the ring or with carbon-carbon double bond or triple bond(s) in the spiro-fused ring are provided herein. These 1,2-dioxetanes have electron donating or withdrawing groups at the four-membered peroxide ring, thus, the 1,2-dioxetanes ring hereof is affected by the added electronic charge.

Abstract: The present invention provides novel 1,2-dioxetanes derived from spiro-fused ketones with or without &pgr;-electrons in the ring or with carbon-carbon double bond(s) in the spiro-fused ring. Additionally, these new dioxetanes have electron donating or withdrawing groups at the four-membered peroxide ring to render these dioxetanes active at all sites.

Abstract: A chemiluminescent 1,2-dioxetane includes an alkaline phosphatase triggerable stable 1,2-dioxetane; a polymeric enhancer which is either an ammonium or phosphonium salt of a polyvinylbenzyl chloride and an aqueous enzyme diluent or stabilizer which corresponds to blood component including blood protein. The system is efficacious for single molecule detection of alkaline phosphatase and other enzymes.

Abstract: Mercury salt-containing discharge effluents such as from B-5 fixatives and PVA fixatives are treated to remove mercury therefrom. The present method contemplates plates the addition of aluminum to the effluent to cause the precipitation of elemental mercury therefrom. The remaining effluent, after precipitation, can be decanted and post treated while recovering precipitated elemental mercury. The decanted effluent, once subjected to post treatment, by first rendering the effluent highly basic, is the neutralized. Neutralization causes the precipitation of sodium chloride. A water conditioner is then added thereto. Subsequently, the so-treated decanted effluent is then filtered through a filtering medium such as filter paper or the like. A second filtration step may then be carried out by passing the so-filtered effluent through a mixed bed or through a filter paper.